The elite rehab center using GLP-1s to treat addiction

Doctors at Caron Treatment Centers say Ozempic has "obliterated" patients' cravings for opioids and alcohol.

July 14, 2025 Check out STAT+

Sponsored By

Rachel Wisniewski for STAT Ozempic for addiction: How an elite rehab center is using GLP-1s to 'obliterate' all kinds of cravings Caron Treatment Centers use GLP-1 drugs in addiction treatment. Doctors say Ozempic has "obliterated" patients' cravings for opioids and alcohol. By Lev Facher and Rachel Wisniewski STAT+ | The growing influence of vaccine skeptics inside HHS Lyn Redwood, former president of the anti-vaccine group Children's Health Defense, is the latest vaccine critic hired by HHS Secretary Robert F. Kennedy Jr. By Chelsea Cirruzzo Court-ordered treatment for serious mental illness is 'inconclusive,' says federal report More states are considering involuntary mental health treatments as a way to address crime and homelessness. By O. Rose Broderick Michael M. Santiago/Getty Images Reports of young children accidentally eating nicotine pouches rose 763% in three years: Study Reports of young children accidentally eating nicotine pouches rose 763% in three years, according to a study By Sarah Todd Opinion: 25 years ago, I reported on horrifying hospital errors. Here's what's changed since then — and what hasn't Operating on the wrong knee, removing an appendix instead of a gallbladder — Larry Tye chronicled those errors 25 years ago. Some things have changed. By Larry Tye STAT+ | Opinion: 11 lessons for health tech startups from one of UpToDate's creators UpToDate has become a juggernaut in health care. Its success offers a blueprint to healthtech startups, particularly in AI. By Peter Bonis ROBERTO SCHMIDT/AFP via Getty Images Opinion: Ending the federal LGBTQ+ suicide prevention line is a public health failure It's a public health failure that the Trump administration is ending the 988 suicide prevention line for LGBTQ+ callers By Jaymes Black and Christine Yu Moutier

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser